Prosecution Insights
Last updated: May 29, 2026
Application No. 18/560,032

SUBSTITUTED BENZAMIDES AS HERBICIDES

Non-Final OA §101§112
Filed
Nov 09, 2023
Priority
May 10, 2021 — IN 202111021131 +1 more
Examiner
SHIN, MONICA A
Art Unit
1616
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Syngenta Crop Protection AG
OA Round
1 (Non-Final)
50%
Grant Probability
Moderate
1-2
OA Rounds
9m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
247 granted / 491 resolved
-9.7% vs TC avg
Strong +47% interview lift
Without
With
+47.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
27 currently pending
Career history
533
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
68.5%
+28.5% vs TC avg
§102
2.7%
-37.3% vs TC avg
§112
3.1%
-36.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 491 resolved cases

Office Action

§101 §112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Status of the Claims Claims 1-14 are pending and under consideration in this action. Claim Objections Claim 1 is objected to because of the following informalities: in line 4, the dash after “wherein:” should be removed. Furthermore, for variables R1, R2, R4, and R5, the dash at the end of each specific group should be removed (e.g., “C1-C4alkyl-” should be “C1-C4alkyl”). Claims 2-9 and 14 are objected to because of the following informalities: Each of the claims recite “[a] compound according to claim …” (or the like); however, each claim is dependent upon, or incorporates, a previously recited claim. As each claim refers to, or incorporates, a previously recited claim, “[a] compound according to claim…” should be “[t]he compound according to claim…”. Claims 10-12 are objected to because of the following informalities: Each of the claims recite “[a] herbicidal composition according to claim …” (or the like); however, each claim is dependent upon, or incorporates, a previously recited claim. As each claim refers to, or incorporates, a previously recited claim, “[a] herbicidal composition according to claim…” should be “[t]he herbicidal composition according to claim…”. Claim 4 is further objected to because of the following informalities: “-SO2methyl” should be “-SO2methyl”. Appropriate corrections are required. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 14 is rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. The claim does not fall within at least one of the four categories of patent eligible subject matter. The claim is directed to a “use” claim that does not purport to claim a process, machine, manufacture, or composition of matter. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 13 and 14 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. With regards to claim 13, the claim recites “making a compound of Formula (I)” but does not recite what Formula (I) is in the claim. Thus, it is unclear what the structure of the final product should be. To address the issue, Examiner suggests amending the claim’s preamble to recite “[a] method of making the compound of Formula (I) according to claim 1, comprising…” or the like. With regards to claim 14, the claim is directed to a “use” claim. The claim, however, is indefinite because it merely recites a use without any active, positive steps delimiting how this use is actually practiced. Note: MPEP 2173.05(q). Allowable Subject Matter Claims 1-14 are free of the prior art. The following is a statement of reasons for the indication of allowable subject matter: The prior art does not appear to disclose or fairly suggest the compound of Formula (I) as recited in claim 1. In particular, the prior art does not disclose the substituent shown on C3 of the substituted benzamide ring. The closest prior art teachings are those of Mitchell et al. (Mitchell) (US 2014/0371067 A1; published Dec. 18, 2014) and Braun et al. (Braun) (US 2012/0058892 A1; published Mar. 8, 2012). Their teachings are set forth herein below. Mitchell discloses a method of controlling weeds at a locus by applying to the locus of a weed controlling amount of a herbicidal composition comprising a compound of Formula (I) (abstract; Mitchell claims 1, 2, 6, 9: PNG media_image1.png 200 400 media_image1.png Greyscale Among the suitable definitions for the above variables include: R1 (corresponding to instant claim 1’s R1) may be C1-C6 alkyl R2 (corresponding to instant claim 1’s R2) may be halogen, C1-C6 alkyl X is CR3 R4 (corresponding to instant claim 1’s O-R3) may be C1-C6haloalkyl, such as trifluoromethyl R5 is hydrogen. Mitchell, however, does not teach or fairly suggest wherein R3 is the substituent shown in the instant claim 1’s Formula (I) on the C3 of the substituted benzamide ring. Braun discloses N-(Tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamides of the formula (I) described as herbicides (abstract; Braun claims 1-13): PNG media_image2.png 200 400 media_image2.png Greyscale Among the suitable definitions for the above variables include: B is N R (corresponding to instant claim 1’s R1) may be C1-C6-alkyl X (corresponding to instant claim 1’s R2) may be halogen, C1-C6-alkyl A is CY Z (corresponding to instant claim 1’s O-R3) may be halo-(C1-C6)-alkyl Braun, however, does not teach or fairly suggest wherein Y is the substituent as shown in the instant claim 1’s Formula (I) on the C3 of the substituted benzamide ring. Conclusion Claims 13 and 14 are rejected. Claims 1-12 are objected to. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MONICA A. SHIN whose telephone number is (571)272-7138. The examiner can normally be reached Monday-Friday (9:00AM-5:00PM EST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sue X Liu can be reached at 571-272-5539. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MONICA A SHIN/Primary Examiner, Art Unit 1616
Read full office action

Prosecution Timeline

Nov 09, 2023
Application Filed
May 06, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635686
COMPOSITIONS AND METHODS FOR IMPOSING SEED QUALITY
6y 1m to grant Granted May 26, 2026
Patent 12589100
HALOBETASOL FOAM COMPOSITION AND METHOD OF MANUFACTURE THEREOF
6y 7m to grant Granted Mar 31, 2026
Patent 12496345
METHOD OF TREATING CANCER
2y 6m to grant Granted Dec 16, 2025
Patent 12490740
ACTIVE COMPOUND COMBINATIONS HAVING INSECTICIDAL PROPERTIES
3y 10m to grant Granted Dec 09, 2025
Patent 12377037
CLEAVABLE COMONOMER STRATEGY FOR ACCELERATING REMOVAL OF GEL NAIL POLISH
1y 1m to grant Granted Aug 05, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
50%
Grant Probability
97%
With Interview (+47.0%)
3y 4m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 491 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month